Light-chain amyloidosis with echocardiographic features of hypertrophic cardiomyopathy

被引:23
作者
Dinwoodey, Danya L. [1 ]
Skinner, Martha [3 ]
Maron, Martin S. [4 ]
Davidoff, Ravin [1 ]
Ruberg, Frederick L. [1 ,2 ,3 ]
机构
[1] Boston Univ, Sch Med, Cardiol Sect, Dept Med, Boston, MA 02215 USA
[2] Boston Univ, Sch Med, Boston Med Ctr, Dept Radiol, Boston, MA 02215 USA
[3] Boston Univ, Amyloid Treatment & Res Program, Boston, MA 02215 USA
[4] Tufts New England Med, Div Cardiol, Hypertroph Cardiomyopathy Ctr, Boston, MA USA
关键词
D O I
10.1016/j.amjcard.2007.10.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertrophic cardiomyopathy and cardiac amyloidosis result in thickening of the left ventricle, as visualized by 2-dimensional echocardiography. Hemodynamically, hypertrophic cardiomyopathy can be typified by a left ventricular outflow tract gradient and systolic anterior motion of the mitral apparatus, findings rarely seen in cardiac amyloidosis. This case series reports 4 patients with cardiac light-chain amyloidosis and left ventricular outflow tract obstruction at rest, suggesting that there may be echocardiographic overlap between these 2 disparate disease processes. In a series of consecutive patients with cardiac light-chain ainyloidosis over a 2-year period, the prevalence of these echocardiographic findings was approximately 4%. In conclusion, awareness of this overlap in echocardiographic presentation may permit more accurate diagnosis, particularly at early stages of amyloid disease, when more treatment options exist. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:674 / 676
页数:3
相关论文
共 14 条
[1]   Surgical pathology of subaortic septal myectomy not associated with hypertrophic cardiomyopathy: A study of 98 cases (1996-2000) [J].
Allen, RD ;
Edwards, WD ;
Tazelaar, HD ;
Danielson, GK .
CARDIOVASCULAR PATHOLOGY, 2003, 12 (04) :207-215
[2]   The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement [J].
Dubrey, SW ;
Cha, K ;
Anderson, J ;
Chamarthi, B ;
Reisinger, J ;
Skinner, M ;
Falk, RH .
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1998, 91 (02) :141-157
[3]   Diagnosis and management of the cardiac amyloidoses [J].
Falk, RH .
CIRCULATION, 2005, 112 (13) :2047-2060
[4]  
GILBERT BW, 1980, AM J CARDIOL, V45, P861, DOI 10.1016/0002-9149(80)90133-2
[5]   Recommendations for chamber quantification [J].
Lang, Roberto M. ;
Bierig, Michelle ;
Devereux, Richard B. ;
Flachskampf, Frank A. ;
Foster, Elyse ;
Pellikka, Patricia A. ;
Picard, Michael H. ;
Roman, Mary J. ;
Seward, James ;
Shanewise, Jack ;
Solomon, Scott ;
Spencer, Kirk T. ;
Sutton, Martin St. John ;
Stewart, William .
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2006, 7 (02) :79-108
[6]   Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy [J].
Maron, MS ;
Olivotto, I ;
Betocchi, S ;
Casey, SA ;
Lesser, JR ;
Losi, MA ;
Cecchi, F ;
Maron, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (04) :295-303
[7]   Dynamic left ventricular outflow tract obstruction in senile cardiac amyloidosis [J].
Mookadam, Farouk ;
Haley, John H. ;
Olson, Lyle J. ;
Cikes, Maja ;
Mookadam, Martina .
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2006, 7 (06) :465-468
[8]   Amyloid heart disease mimicking hypertrophic cardiomyopathy [J].
Mörner, S ;
Hellmann, U ;
Suhr, OB ;
Kazzam, E ;
Waldenström, A .
JOURNAL OF INTERNAL MEDICINE, 2005, 258 (03) :225-230
[9]   Use of percutaneous transluminal septal myocardial ablation for relief of outflow tract obstruction in cardiac arnyloidosis: A novel therapeutic target [J].
Murphy, Ross T. ;
Ratliff, Norman B. ;
Lever, Harry M. ;
Kapadia, Samir R. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 68 (04) :637-641
[10]  
Noma S, 1982, J Cardiogr, V12, P267